Penn State Hershey Melanoma and Skin Cancer Center
Melanoma is the leading cause of death from skin disease – and its rate of occurrence is steadily increasing. In America, one person dies of melanoma every hour. More than 60,000 new cases in the United States are diagnosed each year, and this number is growing at an alarming rate.
In an effort to fight this trend, Penn State Hershey Melanoma and Skin Cancer Center offers a multidisciplinary approach to developing new treatments for melanoma patients. The Melanoma and Skin Cancer Center convenes researchers and clinicians from surgery, dermatology, medical and radiation oncology, pharmacology, orthopedics and other areas with a goal of identifying and evaluating new agents and clinical interventions. Discoveries developed in the research portion of the Melanoma and Skin Cancer Center are tested through a portfolio of clinical trials offered to patients.
Click here to learn more about the next generation of therapies.
"Dead Wrong… It's Only Skin Cancer"
Dead Wrong… It's Only Skin Cancer was produced in 2008 by the Mike Geltrude Foundation of Nutley, NJ. However, this educational documentary is not about Mike Geltrude and his battle against melanoma. In reality, it's about you. The reason is that anyone at any age can be afflicted by this deadly disease and one of the greatest weapons we have to combat melanoma is education. Therefore, taking a half hour to watch this film may save your life and by spreading the word it can save countless lives. As the saying goes, "an ounce of prevention is better than a pound of cure." - Watch Video
- "Dear 16-year old me" (DCMF Canada) - Watch video
- "Myths and facts of Artificial Sun Tanning" - Watch Presentation
The Melanoma and Skin Cancer Center continues to facilitate phase I, II, and III clinical trials of new therapies in its quest to find a cure. Please contact us for information about current clinical trials.
The Melanoma and Skin Cancer Center Skin Oncology Program includes a multidisciplinary clinic for the treatment of melanoma. The Skin Oncology Program's goals include clinical care, research, education, and community outreach.
The Melanoma and Skin Cancer Center's research goal is to unravel the biology and signaling pathways involved in melanoma tumor development to develop the next generation of therapeutic agents to treat this disease.
For more information on the research and clinical activities of the Center, click here
As part of the Penn State Cancer Institute's and the Melanoma and Skin Cancer Center's ongoing efforts to advance and support translational research to find the cure, the Center announces the availability of funding to support projects. The funds available were raised through the Annual Chocolate Tour fundraising effort. For more information on the funds available and how to apply.
Melanoma and Skin Cancer Center Visiting Scholar Lectureship
2011: New Frontiers for Melanoma Centers: "Strategies for diagnosis, management and collaborative research
Presenter: Dr. John Thompson, M.D., Executive Director Melanoma Institute of Australia
2013: Medical Therapy of Melanoma: "Have we gone from zero to sixty?" (Watch presentation)
Presenter: Dr. Sanjiv S. Agarwala, M.D., Director, Melanoma and Immunotherapy Program, St. Luke's Hospital, Temple University
Presenter: Dr. John M. Kirkwood, M.D. Usher Professor of Medicine, Dermatology, and translational Science, Univeristy of Pittsburgh School of Medicine and Director, Melanoma and Skin Cancer Program, Univeristy of Pittsburgh Cancer Institute Hillman Cancer Center.
- The Medical Minute: Clearing up common myths about psoriasis Psoriasis is a misunderstood disease, often kept under wraps by sufferers who want to hide their skin lesions. This week, Dr. Sara Ferguson, a dermatologist at Penn State Medical Group in State College, separates fact from myth about psoriasis and the various treatment options.More...
- How parents cope with stress of the NICU affects family dynamics Understanding how parents cope while their child is in the neonatal intensive care unit (NICU) could lead to better support for the family and a more successful transition to home when the baby is healthy, according to Penn State College of Medicine and Penn State Harrisburg researchers. Parental use of religious and secular coping strategies while their prematurely born baby receives intensive medical care may affect the family's interactions.More...
- Penn State Cancer Institute recognized by Becker’s Hospital Review Penn State Cancer Institute has been named among the “100 Hospitals and Health Systems With Great Oncology Programs” by Becker’s Hospital Review, a leading source of business and legal information for healthcare industry leaders.More...
- New care plan improves outcomes for Crohn's disease complication The first published combined medical and surgical care plan for managing septic perianal Crohn's disease, a serious complication that occurs in around 40 percent of Crohn's disease patients, has been developed by researchers at Penn State College of Medicine. The plan and its results took more than a decade to develop and are based on patient outcomes.More...